Redox modulation of cellular stress response and lipoxin A4 expression by Hericium Erinaceus in rat brain: relevance to Alzheimer’s disease pathogenesis
Open Access
- 9 July 2016
- journal article
- research article
- Published by Springer Nature in Immunity & Ageing
- Vol. 13 (1) , 1-11
Abstract
There has been a recent upsurge of interest in complementary medicine, especially dietary supplements and foods functional in delaying the onset of age-associated neurodegenerative diseases. Mushrooms have long been used in traditional medicine for thousands of years, being now increasingly recognized as antitumor, antioxidant, antiviral, antibacterial and hepatoprotective agent also capable to stimulate host immune responses. Here we provide evidence of neuroprotective action of Hericium Herinaceus when administered orally to rat. Expression of Lipoxin A4 (LXA4) was measured in different brain regions after oral administration of a biomass Hericium preparation, given for 3 month. LXA4 up-regulation was associated with an increased content of redox sensitive proteins involved in cellular stress response, such as Hsp72, Heme oxygenase −1 and Thioredoxin. In the brain of rats receiving Hericium, maximum induction of LXA4 was observed in cortex, and hippocampus followed by substantia Nigra, striatum and cerebellum. Increasing evidence supports the notion that oxidative stress-driven neuroinflammation is a fundamental cause in neurodegenerative diseases. As prominent intracellular redox system involved in neuroprotection, the vitagene system is emerging as a neurohormetic potential target for novel cytoprotective interventions. Vitagenes encode for cytoprotective heat shock proteins 70, heme oxygenase-1, thioredoxin and Lipoxin A4. Emerging interest is now focussing on molecules capable of activating the vitagene system as novel therapeutic target to minimize deleterious consequences associated with free radical-induced cell damage, such as in neurodegeneration. LXA4 is an emerging endogenous eicosanoid able to promote resolution of inflammation, acting as an endogenous “braking signal” in the inflammatory process. In addition, Hsp system is emerging as key pathway for modulation to prevent neuronal dysfunction, caused by protein misfolding. Conceivably, activation of LXA4 signaling and modulation of stress responsive vitagene proteins could serve as a potential therapeutic target for AD-related inflammation and neurodegenerative damage.Keywords
This publication has 44 references indexed in Scilit:
- Markers for the Risk of Progression from Mild Cognitive Impairment to Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2015
- Mushrooms: A Potential Natural Source of Anti-Inflammatory Compounds for Medical ApplicationsMediators of Inflammation, 2014
- Buried treasure: Unlocking the secrets of medicinal mushroomsBiomedical Journal, 2014
- Medicinal mushroom science: Current perspectives, advances, evidences, and challengesBiomedical Journal, 2014
- Effects of β-glucan extracted from Agaricus blazei on the expression of ERCC5, CASP9, and CYP1A1 genes and metabolic profile in HepG2 cellsHuman & Experimental Toxicology, 2013
- Antioxidant and Immunomodulating Activities of Exo-and Endopolysaccharide Fractions from Submerged Mycelia Cultures of Culinary-Medicinal MushroomsInternational Journal of Medicinal Mushrooms, 2013
- Immunosenescence, inflammation and Alzheimer’s diseaseLongevity & Healthspan, 2012
- Anti-inflammation and antioxidant effect of Cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, in middle cerebral artery occlusion-induced focal cerebral ischemia in ratsMetabolic Brain Disease, 2012
- Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative DisordersAntioxidants & Redox Signaling, 2010
- Treatment of Cancer with Mushroom ProductsArchives of Environmental Health: An International Journal, 2003